1. Cell Cycle/DNA Damage Epigenetics Apoptosis
  2. PARP Topoisomerase Apoptosis
  3. TOPOI/PARP-1-IN-1

TOPOI/PARP-1-IN-1 (化合物 B6) 是一种口服有效的、低细胞毒性的 TOPOI/PARP 双重抑制剂,其对 PARP1IC50 值为 0.09 μM。TOPOI/PARP-1-IN-1 能有效抑制癌细胞的增殖和迁移。TOPOI/PARP-1-IN-1 还可导致细胞周期停滞于 G0/G1 期,并诱导细胞凋亡 (apoptosis)。TOPOI/PARP-1-IN-1 对小鼠的肿瘤生长抑制率 (TGI) 为 75.4%。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

TOPOI/PARP-1-IN-1 Chemical Structure

TOPOI/PARP-1-IN-1 Chemical Structure

CAS No. : 2948352-16-5

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

TOPOI/PARP-1-IN-1 (Compound B6) is an orally active, low cytotoxic TOPOI/PARP dual inhibitor with an IC50 value of 0.09 μM for PARP1. TOPOI/PARP-1-IN-1 can effectively inhibit the proliferation and migration of cancer cells. TOPOI/PARP-1-IN-1 also causes cell cycle arrest in the G0/G1 phase and induces apoptosis. The tumor growth inhibition rate (TGI) of TOPOI/PARP-1-IN-1 in mice is 75.4%[1].

IC50 & Target

IC50: 0.09 μM (PARP1)[1].

体外研究
(In Vitro)

TOPOI/PARP-1-IN-1 (1.25-5 μM; 48 h) 以浓度依赖的方式抑制 HGC-27 细胞的增殖和迁移[1]
TOPOI/PARP-1-IN-1 (1.25-5 μM; 24 h) 以剂量依赖的方式诱导 HGC-27 细胞凋亡[1]
TOPOI/PARP-1-IN-1 在 HGC-27 细胞中诱导 DNA 损伤,并抑制 TOPOI 蛋白的表达[1]
TOPOI/PARP-1-IN-1 具有抗肿瘤活性,对 HeLa、A549、HepG-2 和 HGC-27 细胞的 IC50 值分别为 7.21 μM、9.48 μM、3.80 μM 和 2.49 μM[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: HGC-27 cells
Concentration: 1.25, 2.5, 5 μM
Incubation Time: 48 h
Result: Demonstrated dose-dependent inhibitory effect of B6 on the clonogenicity of HGC-27 cells.

Apoptosis Analysis[1]

Cell Line: HGC-27 cells
Concentration: 1.25, 2.5, 5 μM
Incubation Time: 24 h
Result: Induced 15.5%, 43.1% and 76.0% of cell apoptosis when the concentrations were 1.25, 2.5, and 5 μM respectively.
体内研究
(In Vivo)

TOPOI/PARP-1-IN-1 (40 mg/kg; p.o.; once every two days, for a total of 17 days) 抑制异种移植小鼠模型中的 HGC-27 肿瘤生长[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female BALB/c nude mice (xenograft tumor model of HGC-2 cells)[1].
Dosage: 40 mg/kg
Administration: Oral administration; once every two days, for a total of 17 days
Result: Exhibited tumor growth inhibition rate (TGI) of 75.4% in mice.
分子量

718.52

Formula

C36H38Br2N4O2

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
TOPOI/PARP-1-IN-1
目录号:
HY-158138
需求量: